Incidence of Kidney Disease

RECENT NEWS
Forbes  Apr 26  Comment 
Aggressive control of blood pressure has saved millions of lives, and has prevented millions of people from experiencing heart attacks, strokes and kidney failure, among other things. But blood pressure reduction can be too much of a good thing.
The Times of India  Apr 13  Comment 
STOCKHOLM, (BSW) -The five clinical researchers study common diseases such as Parkinson’s, kidney failure, osteoporosis, dementia and cardiovascular diseases.
The Economic Times  Apr 9  Comment 
Scientists, including one of Indian-origin, have identified the key inflammatory mechanisms linked to type 1 diabetes and obesity-related kidney dysfunction.
Benzinga  Mar 29  Comment 
Shares of Keryx Biopharmaceuticals (NASDAQ: KERX), a biopharmaceutical company that focuses on the treatment of renal diseases, gained more than 20 percent early Tuesday morning. Keryx Biopharmaceuticals announced positive top-line results from...
The Australian  Jan 17  Comment 
Vectus Biosystems hopes a local listing will fund its ‘world-beating’ heart and kidney disease treatment.
New York Times  Jan 14  Comment 
Proton pump inhibitors like Nexium, Prevacid and Prilosec may increase the risk of chronic kidney disease.
MedPage Today  Jan 12  Comment 
(MedPage Today) -- Equations more accurate than CKD stage alone, researchers said
Forbes  Jan 12  Comment 
This news may give you some heartburn. A study found that a commonly used type of heartburn medication (proton pump inhibitors or PPIs) may be associated with chronic kidney disease. Any concern about PPI safety raises the question of whether more...




 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki